Merck & Co. (or 'the company'), known as Merck Sharp & Dohme (MSD) outside the US and Canada, is one of the leading healthcare companies in the world. The company is engaged in the research, development, manufacture and marketing of prescription pharmaceuticals, vaccines, biologic therapies, and consumer care and animal health products. It is headquartered in Whitehouse Station, New Jersey, and employed about 76,000 people as of December 31, 2013.
The company recorded revenues of $44,033 million during the financial year ended December 2013 (FY2013), a decrease of 6.8% over FY2012. The operating profit of the company was $5,956 million in FY2013, a decrease of 35.4% over FY2012. The net profit attributable to the company was $4,404 million in FY2013, a decrease of 28.6% over FY2012.
Merck & Co. entered into an agreement in May 2014 to sell its Merck Consumer Care (MCC) business to Bayer AG, a Germany-based global chemical and pharmaceutical business group, for $14.2 billion. In June 2014, Merck & Co. signed a definitive agreement to acquire Idenix Pharmaceuticals, a US-based biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, for $24.50 per share in cash.
Merck & Co., Inc.
One Merck Drive
New Jersey 08889-0100
New York ticker:
No. employees: 76000
Turnover: 44,033,000,000 (USD)
Financial year end: December
- Key facts
- Business Description
- Key Employees and Biographies
- Location and Subsidiaries
- Top Competitors
- Major Products and Services
This SWOT analysis company profile is the essential source for top level data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Scope of this research
- Provides all the crucial company information required for business and competitor intelligence needs.
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Key reasons to purchase this research
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available